• Wed, March 19, 2025

by: MarketWatch

Should 401(k) investors follow the advice of top fund managers?

The positioning of global fund managers is "nowhere near extreme bear/close-your-eyes-and-buy levels" warns BofA Securities in the latest edition of its closely watched monthly survey of fund managers.

by: WOPRAI

Short squeeze is starting in shares of WT at $8.575, after crossing above the $8.547 Trigger Price

by: Kiplinger

Stock Market Today: Stocks Enjoy a Fed Day Relief Rally

The question now is whether Jerome Powell and other policymakers can get the balance right given all the new noise.

by: Morningstar

Explore These 30 Leading Water Funds and Water Stocks in the US and Europe

As of February 2025, we identified 73 open-end funds and ETFs focused on the water theme, including 13 in the US and 60 in Europe, representing a total of $41 billion in assets under management. This universe has grown by almost 70% in the past five years.

by: MiBolsilloColombia

Warren Buffet couldn't have become a millionaire without following these rules

Warren Buffett built his wealth through value investing, patience, and a simple, long-term strategy. His success proves that smart, disciplined investing pays off.

by: Investopedia

Dow Jones Today: Stocks Close Higher as Fed Holds Key Rate Steady, Cites Increased Economic Uncertainty; Boeing, Tesla Among Top Gainers

Stocks closed higher Wednesday as the Federal Reserve decided to leave its key interest rate unchanged while noting that the economic outlook has become more uncertain.

by: Newsweek

Could Elon Musk Face Margin Call Over Tesla Stock? What We Know

Elon Musk may be forced to sell shares previously pledged to secure certain personal loans, should Tesla stock continue to decline. As pointed out by several online commentators, Musk is currently close to facing a margin call on the loans used to facilitate his 2022 purchase of Twitter.

by: AOL

How to Invest in Art: Tips for Choosing and Valuing Artwork

Learning how to invest in art can open up new financial opportunities while allowing you to own pieces of cultural significance. Read on for more:

by: Insider

US households are sitting on record amounts of stock. That could be bad news for the market.

"With this much optimism, one must ask how much liquidity is left around to buy," Ned Davis Research said.

by: SmartAsset

I'm 67 With $2M in an IRA. How Do I Make It Last for Life?

If you had $2 million saved in an individual retirement account (IRA) by age 67, could you make it last the rest of your life? With some wise planning and investing, stretching a $2 million nest egg over several decades is entirely possible.

by: Mint

Unlocking global markets: How Indian investors can diversify with portfolio management services

India's mutual fund industry has hit the cap on investing overseas. But individual investors have an alternative route that could be just as effective for diversifying their investment portfolios.

by: WOPRAI

Short squeeze is starting in shares of VYX at $10.175, after crossing above the $10.114 Trigger Price

by: WOPRAI

Short squeeze is starting in shares of UCBI at $29.28, after crossing above the $29.162 Trigger Price

by: WOPRAI

Short squeeze is starting in shares of TRAK at $19.685, after crossing above the $19.671 Trigger Price

by: WOPRAI

Short squeeze is starting in shares of REGCP at $24, after crossing above the $23.781 Trigger Price

by: WOPRAI

Short squeeze is starting in shares of QXQ at $25.72, after crossing above the $25.349 Trigger Price

by: WOPRAI

Short squeeze is starting in shares of ONTO at $139.26, after crossing above the $137.527 Trigger Price

by: WOPRAI

Short squeeze is starting in shares of LITE at $69.35, after crossing above the $69.325 Trigger Price

by: WOPRAI

Short squeeze is starting in shares of JFBC at $19, after crossing above the $18.973 Trigger Price

by: WOPRAI

Short squeeze is starting in shares of HITI at $2.165, after crossing above the $2.147 Trigger Price

by: WOPRAI

Short squeeze is starting in shares of CAVA at $82.31, after crossing above the $82.04 Trigger Price

by: WOPRAI

Short squeeze is starting in shares of BRPHF at $12.47, after crossing above the $12.363 Trigger Price

by: WOPRAI

Short squeeze is starting in shares of WMS at $112.37, after crossing above the $112.084 Trigger Price

by: WOPRAI

Short squeeze is starting in shares of ENTG at $101.75, after crossing above the $101.481 Trigger Price

by: WOPRAI

Short squeeze is starting in shares of ATMU at $38.72, after crossing above the $38.668 Trigger Price

by: WOPRAI

Short squeeze is starting in shares of WBD at $10.87, after crossing above the $10.752 Trigger Price

by: WOPRAI

Short squeeze is starting in shares of SNPMF at $0.572, after crossing above the $0.569 Trigger Price

by: WOPRAI

Short squeeze is starting in shares of OPGN at $2.35, after crossing above the $2.17 Trigger Price

by: WOPRAI

Short squeeze is starting in shares of ALV at $90.92, after crossing above the $90.664 Trigger Price

by: WOPRAI

Short squeeze is starting in shares of XXII at $1.913, after crossing above the $1.894 Trigger Price

  • Thu, March 20, 2025

by: CoinJournal

Ripple CEO says the SEC will drop its appeal, XRP price reacts higher

Ripple CEO Brad Garlinghouse says the SEC case against the XRP creator is over,with the news catapulting XRP price 12% on Wednesday

by: WOPRAI

As of Mar 20th, 2025, there has been substantial selling of First Hydrogen Corp. in recent trading

by: WOPRAI

As of Mar 20th, 2025, there has been substantial selling of Organovo Holdings, Inc. in recent trading

by: WOPRAI

As of Mar 20th, 2025, there has been substantial selling of Preferred Commerce, Inc. in recent trading

by: WOPRAI

As of Mar 20th, 2025, there has been substantial selling of Arqit Quantum Inc. in recent trading

by: WOPRAI

As of Mar 20th, 2025, there has been substantial selling of GivBux, Inc. in recent trading

by: WOPRAI

As of Mar 20th, 2025, there has been substantial selling of Virpax Pharmaceuticals, Inc. in recent trading

by: WOPRAI

As of Mar 20th, 2025, there has been substantial selling of Can-Fite BioPharma Ltd. in recent trading

by: WOPRAI

As of Mar 20th, 2025, there has been substantial selling of Danimer Scientific, Inc. in recent trading

by: WOPRAI

As of Mar 20th, 2025, there has been substantial selling of Morien Resources Corp. in recent trading

by: WOPRAI

As of Mar 20th, 2025, there has been substantial selling of Black Diamond Therapeutics, Inc. in recent trading

by: WOPRAI

As of Mar 20th, 2025, there has been substantial selling of Netlist, Inc. in recent trading

by: WOPRAI

As of Mar 20th, 2025, there has been substantial selling of Guardforce AI Co., Limited in recent trading

by: WOPRAI

As of Mar 20th, 2025, there has been substantial selling of IRIDEX Corporation in recent trading

by: WOPRAI

As of Mar 20th, 2025, there has been substantial selling of Arbe Robotics Ltd. in recent trading

by: WOPRAI

獁漠⁦慍⁲〲桴‬〲㔲‬桴牥⁥慨⁳敢湥猠扵瑳湡楴污猠汥楬杮漠⁦教扲썡₩牂湡獤䌠牯⹰椠敲散瑮琠慲楤杮

by: WOPRAI

As of Mar 20th, 2025, there has been substantial selling of in recent trading

by: WOPRAI

94 Earnings Releases for Mar 20th, 2025

Should 401(k) investors follow the advice of top fund managers?

The positioning of global fund managers is "nowhere near extreme bear/close-your-eyes-and-buy levels" warns BofA Securities in the latest edition of its closely watched monthly survey of fund managers.
The article from MSN Money discusses whether 401(k) investors should follow the investment strategies of top fund managers. It highlights that while these managers often have impressive track records, their strategies might not be suitable for everyone due to differences in risk tolerance, investment goals, and time horizons. The piece points out that top fund managers frequently invest in high-risk, high-reward assets which might not align with the conservative or balanced approach many 401(k) investors prefer. It also notes the importance of diversification, suggesting that blindly following one manager's strategy could lead to an undiversified portfolio. The article advises that while insights from top fund managers can be valuable, individual investors should consider their personal financial situation, consult with financial advisors, and perhaps use these strategies as part of a broader, personalized investment plan rather than a sole directive.

Read the Full MarketWatch Article at:
https://www.msn.com/en-us/money/savingandinvesting/should-401-k-investors-follow-the-advice-of-top-fund-managers/ar-AA1Bbyw1

Like: 👍